Development of communicating hydrocephalus after infliximab infusion.
Maclennan
Andrew
A
Long
Millie D
MD
Herfarth
Hans H
HH
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D006849:Hydrocephalus / Q000139:chemically induced* / Q000473:pathology; D000069285:Infliximab; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D014057:Tomography, X-Ray Computed; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab